| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |